Whole-Body Dual-Modality PET/CT and Whole-Body MRI for Tumor Staging in Oncology

Abstract

The feasibility and diagnostic accuracy of the whole-body staging strategies of PET/CT and MRI are established. Superior performance in overall TNM staging suggests the use of [18F]-fluorodeoxyglucose-PET/CT as a possible first-line modality for whole-body tumor staging.